• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

农村地区人乳头瘤病毒疫苗接种覆盖率:一项观察性、回顾性队列研究

HPV Vaccination Coverage Rate in a Rural Area: An Observational, Retrospective, and Cohort Study.

作者信息

Colomé-Ceballos Lara, Clua-Espuny Josep Lluís, Fernández-Sáez José, Ceballos-García Concepción, Andrés-Cubells Natàlia, Pla-Farnós Maria Jesús

机构信息

Sexual and Reproductive Attention, SAP Terres de l'Ebre, Catalonian Health Institute, 43500 Tortosa, Spain.

Gynaecology Department, Hospital Verge de la Cinta de Tortosa, Catalonian Health Institute, 43500 Tortosa, Spain.

出版信息

Vaccines (Basel). 2022 Aug 7;10(8):1274. doi: 10.3390/vaccines10081274.

DOI:10.3390/vaccines10081274
PMID:36016161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9414211/
Abstract

In order to reduce the incidence and mortality rate of cervical cancer, the World Health Organization (WHO) declared the Global Strategy Goal for 2030, advocating for reaching a vaccination coverage rate of >90% against human papillomavirus for girls by the age of 15 years. The main objectives of this study were (1) to determine the papillomavirus vaccination coverage among women 15−40 years old and (2) to identify the at-risk subgroups and possible barriers to achieving WHO’s 2030 goal. Multicentre, observational, retrospective, and community-based cohort studies were conducted on women from a rural area in southern Catalonia until 31 December 2021. A total of 23,136 women were included, with a mean age of 26.6 (SD = 5.6) years. The average dose number was 1.7 (SD = 0.7). The results showed overall vaccination coverage of 17.4% among the target women. This coverage was unequal across regions (16.6−24.5%, p < 0.001), primary healthcare teams (15.5−24.3%, p < 0.001), and age groups (56.7% (15−19-year-olds) vs. 3.8% (35−40-year-olds), p < 0.001), related to accessibility to vaccination and economic−geographical indicators. Clinical practice guidelines on screening individuals at risk in terms of vaccination access and public vaccination protocols should be implemented in order to improve the vaccination coverage rate.

摘要

为降低宫颈癌的发病率和死亡率,世界卫生组织(WHO)宣布了2030年全球战略目标,倡导15岁女孩的人乳头瘤病毒疫苗接种覆盖率达到90%以上。本研究的主要目的是:(1)确定15至40岁女性的乳头瘤病毒疫苗接种覆盖率;(2)确定高危亚组以及实现WHO 2030年目标的可能障碍。对加泰罗尼亚南部农村地区的女性进行了多中心、观察性、回顾性和基于社区的队列研究,直至2021年12月31日。共纳入23136名女性,平均年龄为26.6(标准差=5.6)岁。平均接种剂数为1.7(标准差=0.7)。结果显示,目标女性的总体疫苗接种覆盖率为17.4%。不同地区(1,6.6−24.5%,p<0.001)、基层医疗团队(15.5−24.3%,p<0.001)和年龄组(15至19岁组为56.7%,35至40岁组为3.8%,p<0.001)的覆盖率不平等,这与疫苗接种的可及性和经济地理指标有关。应实施关于筛查接种风险个体的临床实践指南以及公共疫苗接种方案,以提高疫苗接种覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/9414211/56d07ae83a57/vaccines-10-01274-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/9414211/56d07ae83a57/vaccines-10-01274-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/9414211/56d07ae83a57/vaccines-10-01274-g0A1.jpg

相似文献

1
HPV Vaccination Coverage Rate in a Rural Area: An Observational, Retrospective, and Cohort Study.农村地区人乳头瘤病毒疫苗接种覆盖率:一项观察性、回顾性队列研究
Vaccines (Basel). 2022 Aug 7;10(8):1274. doi: 10.3390/vaccines10081274.
2
Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.在马拉维实施人乳头瘤病毒疫苗示范项目:成功经验与挑战
BMC Public Health. 2017 Jun 26;17(1):599. doi: 10.1186/s12889-017-4526-y.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.全球人乳头瘤病毒疫苗接种覆盖率的估计:国家层面指标分析。
BMJ Open. 2021 Sep 2;11(9):e052016. doi: 10.1136/bmjopen-2021-052016.
5
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
6
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.实现世界卫生组织宫颈癌消除目标的死亡率影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):591-603. doi: 10.1016/S0140-6736(20)30157-4. Epub 2020 Jan 30.
7
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?对男孩进行HPV-16/18 AS04佐剂疫苗接种或对11岁以上女孩进行补种:在意大利,预防宫颈癌的最大益处在哪里?
BMC Infect Dis. 2015 Sep 17;15:377. doi: 10.1186/s12879-015-1067-9.
8
The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.人乳头瘤病毒疫苗在西班牙初级保健机构获批后的首个十年中的纵向接种率
Pharmaceut Med. 2019 Dec;33(6):519-530. doi: 10.1007/s40290-019-00309-9.
9
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.宫颈癌及相关宫颈疾病的预防:致癌性人乳头瘤病毒(HPV)疫苗接种的成本效益综述
J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217.
10
Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention.意大利消除宫颈癌:基于价值的预防的现状和未来努力。
Front Public Health. 2022 Nov 30;10:1010237. doi: 10.3389/fpubh.2022.1010237. eCollection 2022.

引用本文的文献

1
Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case-Control Study.了解人乳头瘤病毒疫苗接种的预后因素:一项农村社区病例对照研究。
Vaccines (Basel). 2023 Sep 28;11(10):1536. doi: 10.3390/vaccines11101536.
2
Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination.罗马尼亚人乳头瘤病毒(HPV)疫苗接种的障碍与促进因素
Vaccines (Basel). 2022 Oct 15;10(10):1722. doi: 10.3390/vaccines10101722.

本文引用的文献

1
One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer.一剂人乳头瘤病毒(HPV)疫苗可为预防宫颈癌提供可靠的保护。
Saudi Med J. 2022 May;43(5):538.
2
HPV vaccination coverage in women between 15 and 55 years old in Spain: Temporal trend during the period 2007-2020.西班牙15至55岁女性的人乳头瘤病毒疫苗接种覆盖率:2007年至2020年期间的时间趋势
Int J Gynaecol Obstet. 2022 Sep;158(3):705-713. doi: 10.1002/ijgo.14067. Epub 2022 Jan 7.
3
A Call for Low- and Middle-Income Countries to Commit to the Elimination of Cervical Cancer.
呼吁低收入和中等收入国家致力于消除宫颈癌。
Lancet Reg Health Am. 2021 Oct;2:None. doi: 10.1016/j.lana.2021.100036.
4
Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis.亚洲和非洲的 HPV 疫苗和非疫苗型别流行率及多重 HPV 感染的种族差异:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2729-2741. doi: 10.31557/APJCP.2021.22.9.2729.
5
Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.全球人乳头瘤病毒疫苗接种覆盖率的估计:国家层面指标分析。
BMJ Open. 2021 Sep 2;11(9):e052016. doi: 10.1136/bmjopen-2021-052016.
6
Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies.微小核糖核酸在人乳头瘤病毒和人类免疫缺陷病毒相关恶性肿瘤的肛门癌筛查中的潜在作用
World J Gastrointest Pathophysiol. 2021 Jul 22;12(4):59-83. doi: 10.4291/wjgp.v12.i4.59.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.HPV 疫苗接种在全球范围内的推广情况以及世卫组织和儿基会对 2010-2019 年各国 HPV 免疫接种覆盖率的估计。
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
9
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries.9 个欧洲国家参加宫颈癌筛查的成年女性 HPV 疫苗接种率的决定因素。
Am J Prev Med. 2021 Apr;60(4):478-487. doi: 10.1016/j.amepre.2020.08.032. Epub 2020 Dec 24.
10
Development and first application of an audit system for screening programs based on the PRECEDE-PROCEED model: an experience with breast cancer screening in the region of Lombardy (Italy).基于 PRECEDE-PROCEED 模式的筛查项目审核系统的开发与首次应用:在意大利伦巴第大区(意大利)进行乳腺癌筛查的经验。
BMC Public Health. 2020 Nov 25;20(1):1778. doi: 10.1186/s12889-020-09842-8.